Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PROCEPT BioRobotics Q4 2023 GAAP EPS $(0.54) Misses $(0.44) Estimate, Sales $43.58M Beat $42.06M Estimate

Author: Benzinga Newsdesk | February 27, 2024 05:28pm
PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.44) by 22.73 percent. This is a 14.29 percent increase over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $43.58 million which beat the analyst consensus estimate of $42.06 million by 3.61 percent. This is a 83.29 percent increase over sales of $23.78 million the same period last year.

Posted In: PRCT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist